Recombinant Human Anti-C17H32O2 Soluble TCR (BC2) (C-Cys) (CAT#: VS-0622-YF4189)
Human TCR (BC2) recognizes C17H32O2 peptide (methyl palmitoleate) in the context of CD1a. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- C17H32O2
- Epitope
- methyl palmitoleate
- MHC
- CD1a
- Clone
- BC2
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- C17H32O2; methyl palmitoleate
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone BC2"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4189. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, ELISA, FuncS
-2.png)
Application: IB, ELISA, FC, FuncS
Application: Neut, FC
Application: FC, ADCC, CDC, Inhib
Application: ELISA, Neut
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
